发明授权
- 专利标题: Modified CEA nucleic acid and expression vectors
- 专利标题(中): 修饰的CEA核酸和表达载体
-
申请号: US13532035申请日: 2012-06-25
-
公开(公告)号: US08530442B2公开(公告)日: 2013-09-10
- 发明人: Mark Parrington , Linong Zhang , Benjamin Rovinski , Linda R. Gritz , Patricia Greenhalgh
- 申请人: Mark Parrington , Linong Zhang , Benjamin Rovinski , Linda R. Gritz , Patricia Greenhalgh
- 申请人地址: CA Toronto, Ontario
- 专利权人: Sanofi Pasteur Limited
- 当前专利权人: Sanofi Pasteur Limited
- 当前专利权人地址: CA Toronto, Ontario
- 代理商 Patrick J. Halloran; Reza Yacoob
- 主分类号: A61K48/00
- IPC分类号: A61K48/00
摘要:
The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. The invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. One such foreign DNA sequence is modified CEA nucleic acid.
公开/授权文献
- US20130101625A1 MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS 公开/授权日:2013-04-25